Concepedia

Pamela Moise

PM

Statistics

Publications

27

Citations

1.8K

H-Index

20

Active since

1994

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Cubist Pharmaceuticals (United States)

New York Medical College

University at Buffalo, State University of New York

University of California San Diego

Pamela Moise is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in infectious diseases, medical microbiology, and antibiotic resistance.

Publications per year

1994–2023

27

Publications

27

Vancomycin In Vitro Bactericidal Activity and Its Relationship to Efficacy in Clearance of Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia

Pamela Moise, George Sakoulas, Alan Forrest et al. · Antimicrobial Agents and Chemotherapy · 2007 · 225 citations · Full text

, , +17

Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin Plus Ceftaroline

George Sakoulas, Pamela Moise, Anthony M. Casapao et al. · Clinical Therapeutics · 2014 · 182 citations · Full text

, , +12

Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus faecium

George Sakoulas, Arnold S. Bayer, Joseph Pogliano et al. · Antimicrobial Agents and Chemotherapy · 2011 · 174 citations · Full text

, , +17

Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureus

Pamela Moise, Alan Forrest, Sujata M. Bhavnani et al. · American Journal of Health-System Pharmacy · 2000 · 165 citations

, , +15

Safety and Clinical Outcomes when Utilizing High-Dose (≥8 mg/kg) Daptomycin Therapy

Pamela Moise, Ellie Hershberger, Maria Amodio-Groton et al. · Annals of Pharmacotherapy · 2009 · 134 citations

, , +14

1–5 of 27